Nicholas A Saccomano - Net Worth and Insider Trading
Nicholas A Saccomano Net Worth
The estimated net worth of Nicholas A Saccomano is at least $6 Million dollars as of 2025-07-23. Nicholas A Saccomano is the CSO of Array BioPharma Inc and owns about 142,488 shares of Array BioPharma Inc (ARRY) stock worth over $6 Million. Nicholas A Saccomano is also the President and CEO of OnKure Therapeutics Inc and owns about 3,594 shares of OnKure Therapeutics Inc (OKUR) stock worth over $8,392. Details can be seen in Nicholas A Saccomano's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nicholas A Saccomano has not made any transactions after 2025-06-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Nicholas A Saccomano
Nicholas A Saccomano Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nicholas A Saccomano owns 1 companies in total, including OnKure Therapeutics Inc (OKUR) .
Click here to see the complete history of Nicholas A Saccomano’s form 4 insider trades.
Insider Ownership Summary of Nicholas A Saccomano
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
OKUR | OnKure Therapeutics Inc | 2024-10-04 | director & President and CEO |
Nicholas A Saccomano Latest Holdings Summary
Nicholas A Saccomano currently owns a total of 2 stocks. Among these stocks, Nicholas A Saccomano owns 142,488 shares of Array BioPharma Inc (ARRY) as of February 7, 2019, with a value of $6 Million and a weighting of 99.85%. Nicholas A Saccomano also owns 3,594 shares of OnKure Therapeutics Inc (OKUR) as of June 23, 2025, with a value of $8,392 and a weighting of 0.15%.
Latest Holdings of Nicholas A Saccomano
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ARRY | Array BioPharma Inc | 2019-02-07 | 142,488 | 38.95 | 5,549,908 |
OKUR | OnKure Therapeutics Inc | 2025-06-23 | 3,594 | 2.34 | 8,392 |
Holding Weightings of Nicholas A Saccomano
Nicholas A Saccomano Form 4 Trading Tracker
According to the SEC Form 4 filings, Nicholas A Saccomano has made a total of 0 transactions in Array BioPharma Inc (ARRY) over the past 5 years. The most-recent trade in Array BioPharma Inc is the sale of 187,264 shares on February 7, 2019, which brought Nicholas A Saccomano around $4 Million.
According to the SEC Form 4 filings, Nicholas A Saccomano has made a total of 2 transactions in OnKure Therapeutics Inc (OKUR) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in OnKure Therapeutics Inc is the sale of 88 shares on June 23, 2025, which brought Nicholas A Saccomano around $209.
Insider Trading History of Nicholas A Saccomano
- 1
Nicholas A Saccomano Trading Performance
Nicholas A Saccomano Ownership Network
Ownership Network List of Nicholas A Saccomano
Ownership Network Relation of Nicholas A Saccomano

Nicholas A Saccomano Owned Company Details
What does OnKure Therapeutics Inc do?
Who are the key executives at OnKure Therapeutics Inc?
Nicholas A Saccomano is the director & President and CEO of OnKure Therapeutics Inc. Other key executives at OnKure Therapeutics Inc include 10 percent owner Acorn Capital Advisors Gp 2, Llc , 10 percent owner Acorn Bioventures 2, L.p. , and Chief Scientific Officer Dylan Hartley .
OnKure Therapeutics Inc (OKUR) Insider Trades Summary
Over the past 18 months, Nicholas A Saccomano made 2 insider transaction in OnKure Therapeutics Inc (OKUR) with a net sale of 962. Other recent insider transactions involving OnKure Therapeutics Inc (OKUR) include a net sale of 1,837,739 shares made by Cormorant Global Healthcare Master Fund, Lp , a net sale of 3,425 shares made by Jason A. Leverone , and a net purchase of 1,400,000 shares made by Acorn Bioventures, L.p. .
In summary, during the past 3 months, insiders sold 1,838,130 shares of OnKure Therapeutics Inc (OKUR) in total and bought 1,400,000 shares, with a net sale of 438,130 shares. During the past 18 months, 1,842,126 shares of OnKure Therapeutics Inc (OKUR) were sold and 1,400,000 shares were bought by its insiders, resulting in a net sale of 442,126 shares.
OnKure Therapeutics Inc (OKUR)'s detailed insider trading history can be found in Insider Trading Tracker table.
OnKure Therapeutics Inc Insider Transactions
Nicholas A Saccomano Mailing Address
Above is the net worth, insider trading, and ownership report for Nicholas A Saccomano. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Nicholas A Saccomano's mailing address is: Boulder Co 80301.